Health Care/Hospital

EXCELLENT CLINICAL DATA FOR SUBB2M/CA15-3 BREAST CANCER TEST

* INOVIQ's SubB2M/CA15-3 breast cancer test detects all-stages of breast cancer with excellent accuracy (87%), sensitivity (81%) and specificity (93%) * The results of a comprehensive 483-sample case-control study established that INOVIQ's SubB2M/CA15-3 blood test significantly outperformed a ...

2023-06-27 19:00 1872

Innovative paper-like, battery-free, AI-enabled sensor for holistic wound monitoring

SINGAPORE, June 27, 2023 /PRNewswire/ -- Timely and effective monitoring of wound healing status is critical to wound care and management. Impaired wound healing, such as chronic wounds (i.e. those that do not heal after 3 months) and post-burn pathological scars, could result in life-threatening...

2023-06-27 16:53 1900

PM International celebrates its 30th anniversary

MANNHEIM, Germany, June 27, 2023 /PRNewswire/ -- One of the world's most successful direct selling companies, PM-International, celebrates its birthday: A two-day event in the Rosengarten and the SAP Arena inMannheim marks the 30th anniversary of one of the world's leading direct sales companies ...

2023-06-27 16:00 3956

Pharmadule Morimatsu and WuXi Biologics Reached Global Strategic Partnership

SHANGHAI, June 27, 2023 /PRNewswire/ -- June 26th, 2023, Pharmadule Morimatsu and WuXi Biologics officially entered into a global strategic cooperation for the Singapore CRDMO Center project of WuXi Biologics. As leaders in their respective...

2023-06-27 15:33 2279

Momcozy Aims to Empower Breastfeeding Moms with Online Seminar After Successful FIME 2023 Exhibit

NEW YORK, June 26, 2023 /PRNewswire/ -- Momcozy , the renowned maternity and baby brand endorsed by over two million moms globally, has announced it will host an online breastfeeding seminar onJuly 13 to provide more professional support to moms following its impressive prod...

2023-06-27 10:00 1542

UOB launches first Wellness Festival highlighting importance of financial wellness to customers' holistic well-being

SINGAPORE, June 27, 2023 /PRNewswire/ -- UOB on Tuesday launched its inaugural Wellness Festival at the UOB Plaza atrium, with booths, workshops and stage activities showcasing the Bank's myriad array of wellness propositions promoting holistic well-being that it offers to customers. The UOB W...

2023-06-27 10:00 3454

AXA Brings Positivity and Peace of Mind to Retirees with New JoyAhead Immediate Annuity Plan

Immediate access to lifelong guaranteed monthly income Doubled monthly payout for extra support in case of Severe Dementias HONG KONG, June 26, 2023 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) today announced the launch of its first immediate annuity productJoyAhead Immediate Annuity Pla...

2023-06-27 08:50 1964

Lion TCR Secures USD 40 million Series B2 Financing, Revolutionizing Solid Tumor Treatment with mRNA-Encoding TCR-T Cell Therapy

SINGAPORE and GUANGZHOU, China, June 27, 2023 /PRNewswire/ -- 27 June 2023, Lion TCR, a clinical-stage T-cell immunotherapy company, is thrilled to announce the successful completion of itsUSD 40 million Series B2 financing round. Guangzhou Industrial Investment and Capital Operation Holding Grou...

2023-06-27 08:30 2629

CStone announces GAVRETO® (pralsetinib) sNDA approval by China NMPA for first-line treatment of patients with locally advanced or metastatic RET fusion-positive non-small cell lung cancer

* The approval for the first-line treatment of RET fusion-positive non-small cell lung cancer marks the third indication of GAVRETO in Mainland China, and the eleventh new drug application approval that CStone has obtained inGreater China overall. * In the ARROW study, GAVRETO had demonstrate...

2023-06-27 08:05 2226

New ZIRCON Phase III Data Presented at SNMMI: Potential Utility of TLX250-CDx in Staging and Monitoring ccRCC

MELBOURNE, Australia, June 27, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces further details of the positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr-DFO-girentuximab) in clear cell renal cell carcinoma (ccRC...

2023-06-27 03:51 1884

DentalMonitoring reinvents the scan experience

PARIS and AUSTIN, Texas, June 26, 2023 /PRNewswire/ -- DentalMonitoring announces their latest innovation, ScanAssist, the only AI-guided scan process available in orthodontics, designed to provide a fun, engaging patient experience, while also providing unprecedented photo quality for clinical ...

2023-06-26 23:43 2077

HitGen launches a newly upgraded version of OpenDEL™, a self-service screening kit, to facilitate innovative drug discovery research

CHENGDU, China, June 26, 2023 /PRNewswire/ -- HitGen Inc. ("HitGen", SSE: 688222.SH) has recently launched a newly upgraded version of its OpenDEL™ product, a self-service screening kit for novel molecules. It contains 65% more DEL libraries than the previous version, and with over 3 billion comp...

2023-06-26 21:30 2151

CXR-AID, Powered by Lunit, Nets Japan Nod for Reimbursement, Accelerating Market Expansion Opportunities

- Medical AI solutions, including CXR-AID, officially included in Japanese health insurance reimbursement as a management service fee of imaging diagnosis SEOUL, South Korea, June 26, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a global provider of cancer diagnostics solutions, today announced th...

2023-06-26 21:00 2425

Angel Yeast Inks Agreements with Hubei Academy of Agricultural Sciences to Boost Agricultural Industrialization

YICHANG, China, June 26, 2023 /PRNewswire/ -- Angel Yeast (SHA:600298), the world's leading yeast manufacturer, recently inked agreements with Hubei Academy of Agricultural Sciences to conduct research and development initiatives in agricultural microbiology and plan...

2023-06-26 20:00 2335

MEDICAL IP Received US FDA 510(k) Clearance for DeepCatch, AI Software for Whole-Body Composition CT Quantification

* The world's first FDA cleared solution that automatically analyzes bone, muscle, visceral fat, subcutaneous fat, internal organ, and central nervous system in whole-body CT * Validation using multi-site and multi-racial CT data in the US… "We will create a new global standard for body com...

2023-06-26 19:00 1664

CPIC Life (H.K.) won "Cross-Border Insurance Services - Excellence Award" and "Service Innovation - Outstanding Award"

HONG KONG, June 26, 2023 /PRNewswire/ -- China Pacific Life Insurance (H.K.) Company Limited ("CPIC Life (HK)" or "the Company") scored 2 awards at "Financial Institution Awards 2023", including "Cross-Border Insurance Services – Excellence Award" and "Service Innovation – Outstanding Award", rec...

2023-06-26 18:05 2917

Yili Shares lts Dairy Innovations at the Global Dairy Congress

LONDON, June 26, 2023 /PRNewswire/ -- From June 21 to 22, the 16th Global Dairy Congress, themed "Reimagining Dairy," took place as a platform for exchanging views on the high-quality development of the dairy industry. Participants included representatives from dairy producers, scholars, experts,...

2023-06-26 16:21 2267

VitaDairy Vietnam Secures the No. 1 Partner of Global Colostrum Leader

VitaDairy Vietnam Joint Stock Company (VitaDairy), a prominent player among  Vietnam's top three largest powdered milk manufacturers, has achieved a significant milestone by establishing itself as the No.1 partner of Pantheryx ( USA), the world's largest colostrum manufacturing group. The certifica...

2023-06-26 09:30 2148

Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening

Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT - Insighta is a 50/50 Joint Venture by Prenetics and Professor Dennis Lo. - Insighta is powered by technology developed by the Centre for Novostics which is supported by the InnoHK Initiative of the Innovati...

2023-06-26 08:45 2656

Ascletis Announces Poster Presentation of Phase II Study of ASC42 FXR Agonist for Functional Cure of Chronic Hepatitis B at EASL CONGRESS 2023

HANGZHOU and SHAOXING, China, June 26, 2023 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") today announces the poster presentation of ASC42, a novel farnesoid X receptor (FXR) agonist, in combination with PEGylated interferon (PEG-IFN) and entecavir (ETV) in chronic hepatitis B (...

2023-06-26 08:10 2656
1 ... 139140141142143144145 ... 810